ADA AmGricsn 211 East chica9 A^nue

Size: px
Start display at page:

Download "ADA AmGricsn 211 East chica9 A^nue 1312.440.2500"

Transcription

1 Microsoft Word - Dental Amalgam What Others Say final... ADA AmGricsn 211 East chica9 A^nue Chicago, Illinois F vvwvv.ada.org Association America's leading advocate for oral health 'What Others Say" About Dental Amalgam Last Updated: March 27, 2O13 Alzheimer's Association: "According to the best available scientific evidence, there is no relationship between silver dental fillings and Alzheimer's.... Many scientists consider these studies compelling evidence that dental amalgam is not a major risk factor for Alzheimer's disease": 1) March 1991, the Dental Devices Panel of the FDA concluded there was no current evidence that amalgam poses any danger 2) National Institutes of Health (NIH) in 1991 funded a study at the University of Kentucky to investigate the relationship between amalgam fillings and Alzheimer's. Analysis by University statisticians revealed no significant association between silver fillings and Alzheimer's; 3) October 30, 2003, a New England Journal of Medicine article concluded that current evidence shows no connection between mercury-containing dental fillings and Alzheimer's or other neurological diseases. The abstract for this study is posted on the New England Journal of Medicine Web site. Source: disease myths about alzheimers.asp American Academy of Pediatrics: "Although dental amalgams are a source of mercury exposure and are associated with slightly higher urinary mercury excretion, there is no scientific evidence of any measurable clinical toxic effects other than rare hypersensitivity reactions. An expert panel for the National Institutes of Health has concluded that existing evidence indicates dental amalgams do not pose a health risk and should not be replaced merely to decrease mercury exposure." Source: Autism Society of America: "There is no known single cause for autism, but it is generally accepted that it is caused by abnormalities in brain structure or function. Brain scans show differences in the shape and structure of the brain in children with autism versus neuro-typical children. Researchers are investigating a number of theories, including the link between heredity, genetics and medical problems. In many families, there appears to be a pattern of autism or related disabilities, further supporting a genetic basis to the disorder. While no one gene has been identified as causing autism, researchers are searching for irregular segments of genetic code that children with autism may have inherited. It also appears that some children are born with a susceptibility to autism, but researchers have not yet identified a single "trigger" that causes autism to develop." Source: Iof3 3/29/2013 7:08 AM

2 Microsoft Word - Dental Amalgam What Others Say ISfinaL... U.S. Environmental Protection Agency: "Since the 1990s, several federal agencies have reviewed the scientific literature looking for links between dental amalgam and health problems. According to the Centers for Disease Control and Prevention (CDC), there is little scientific evidence that the health of the vast majority of people with dental amalgam is compromised, nor that removing amalgam fillings has any beneficial effect on health." Source: Mayo Clinic: "Amalgam fillings are safe. A great deal of research has examined these fillings and found them to be an effective, long-lasting treatment for dental decay. Amalgam, or silver, fillings are made with mercury, silver, tin and copper. In some cases, other metals may be included in amalgam fillings, too. Amalgam has been used for many years to replace decayed areas within teeth. It's an excellent material for this purpose. Amalgam is a strong, stable substance that holds up well when placed in a moist environment. It's also a good choice because it can tolerate the dramatic changes in temperature within your mouth." Source: "Amalgam is a safe and durable choice for fillings" in Medical Edge from Mayo Clinic January 28, National Multiple Sclerosis Society: "There is no scientific evidence to connect the development or worsening of MS with dental fillings containing mercury, and therefore no reason to have those fillings removed. Although poisoning with heavy metals-such as mercury, lead, or manganese-can damage the nervous system and produce symptoms such as tremor and weakness, the damage is inflicted in a different way than occurs in MS and the process is also different." Source: alternatlve-medlclne/lndex.aspx "There have been claims over the years that mercury leaking from amalgam dental fillings damages the immune system and causes a broad range of diseases, including MS. While the cause of MS remains unknown, there is no scientific evidence that heavy metal poisoning is responsible for either the onset or worsening of MS. There is no reason to have your dental fillings removed or replaced. This is a very expensive procedure with no proven benefit for people with MS." Source: "Dental Health" brochure U.S. Food and Drug Administration: "FDA has reviewed the best available scientific evidence to determine whether the low levels of mercury vapor associated with dental amalgam fillings are a cause for concern. Based on this evidence, FDA considers dental amalgam fillings safe for adults and children ages 6 and above. The amount of mercury measured in the bodies of people with dental amalgam fillings is well below levels associated with adverse health effects... FDA concludes that the existing data support a finding that infants are not at risk for adverse health effects from the breast 2 of 3 3/29/2013 7:08 AM

3 Microsoft Word - Dental Amalgam What Others Say final... milk of women exposed to mercury vapor from dental amalgam. The estimated daily dose of mercury vapor in children under age 6 with dental amalgams is also expected to be at or below levels that the EPA and CDC consider safe." Source: ml71094.htm New England Journal of Medicine: "Current concern arises from claims that long-term exposure to low concentrations of mercury vapor from amalgams either causes or exacerbates degenerative diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, multiple sclerosis, and Parkinson's disease. Speculation has been most intense with respect to Alzheimer's disease after a report that the brains of patients with Alzheimer's disease had elevated mercury concentrations. However, several epidemiological investigations failed to provide evidence of a role of amalgam in these degenerative diseases... Patients who have questions about the potential relation between mercury and degenerative diseases can be assured that the available evidence shows no connection." Source: New England Journal of Medicine 349; 18, October 30, 2003, pp I nternational Journal of Dentistry: "According to the available articles and data reviewed in this paper, the following conclusions can be drawn: 1) Mercury released from dental amalgam restorations does not contribute to systemic disease or systemic toxicological effects, 2) Allergic reactions to mercury from dental amalgam restorations have been demonstrated, but these are extremely rare, and 3) Available scientific data do not justify the discontinuation of dental amalgam use from clinical practice or the replacement with other single-tooth restorative dental materials." Source: "Biocompatibility of Dental Amalgams" November National Council Against Health Fraud: "The National Council Against Health Fraud believes that amalgam fillings are safe..." "There is no logical reason to worry about the safety of amalgam fillings." Source: National Council Against Health Fraud Web site The National Institute of Dental and Craniofacial Research (NIDCR - part of the National Institutes of Health): "Both studies one conducted in Europe, the other in the United States independently reached the conclusion: Children whose cavities were filled with dental amalgam had no adverse health effects. The findings included no detectable loss of intelligence, memory, coordination, concentration, nerve conduction, or kidney function during the 5-7 years the children were followed." Source: Studies Evaluate Health Effects of Dental Amalgam Fillings in Children PR htm 3of3 3/29/2013 7:08 AM

4 Statement on Dental Amalgam - American Dental Association - ADA.org ADA Council on Scientific Affairs Dental amalgam is considered a safe, affordable and durable material that has been used to restore the teeth of more than 100 million Americans. It contains a mixture of metals such as silver, copper and tin, in addition to mercury, which binds these components into a hard, stable and safe substance. Dental amalgam has been studied and reviewed extensively, and has established a record of safety and effectiveness. The FDI World Dental Federation and the World Health Organization concluded in a 1997 consensus statement1: "No controlled studies have been published demonstrating systemic adverse effects from amalgam restorations." Another conclusion of the report stated that, aside from rare instances of local side effects of allergic reactions, "the small amount of mercury released from amalgam restorations, especially during placement and removal, has not been shown to cause any... adverse health effects." In 1998 the ADA'S Council on Scientific Affairs" published its first major review of the scientific literature on dental amalgam which concluded that "based on available scientific information, amalgam continues to be a safe and effective restorative material." The Council's report also stated, "There currently appears to be no justification for discontinuing the use of dental amalgam." In an article"' published in the February 1999 issue of the Journal of the American Dental Association, researchers report finding "no significant assoaation of Alzheimer's Disease with the number, surface area or history of having dental amalgam restorations" and "no statistically significant differences in brain mercury levels between subjects with Alzheimer's Disease and control subjects." A 2003 paper published in the New England Journal of Medicine" states, "Patients who have questions about the potential relation between mercury and degenerative diseases can be assured that the available evidence shows no connection." In 2004, an expert panel reviewed the peer-reviewed, scientific literature published from 1996 to December 2003 on potential adverse human health effects caused by dental amalgam and published a report. The review was conducted by the Life Sciences Research Office (LSRO) and funded by the National Institutes of Dental and Craniofacial Research, National Institutes of Health and the Centers for Devices and Radiological Health, U.S. Food and Drug Administration (FDA). The resulting report states that, "The current data are insufficient to support an association between mercury release from dental amalgam and the various complaints that have been attributed to this restoration material These complaints are broad and nonspecific compared to the well-defined set of effects that have been documented for occupational and accidental elemental mercury exposures. Individuals with dental amalgam-attributed complaints had neither elevated urinary mercury nor increased prevalence of hypersensitivity to dental amalgam or mercury when compared with controls." The full report is available from LSRO ( A summary of the review is published in Toxicological Reviews." In 2006, the Journal of the American Medical Association (JAMA) and Environmental Health Perspectives published the results of two independent clinical trials designed to examine the effects of mercury release from amalgam on the central and peripheral nervous systems and kidney function. The authors concluded that "there were no statistically significant differences in adverse neuropsychological or renal effects observed over the 5-year period in children whose caries are restored using dental amalgam or composite materials";1"/" and "children who received dental restorative treatment with amalgam did not, on average, have statistically significant differences in neurobehavioral assessments or in nerve conduction velocity when compared with children who received resin composite materials without amalgam These findings, combined with the trend of higher treatment need later among those receiving composite, suggest that amalgam should remain a viable dental restorative option for children."7'" In May 2008, a Scientific Committee of the European Commission addressed safety concerns for patients, professionals and the use of alternative restorative materials.'" The committee concluded that dental amalgams are effective and safe, both for patients and dental personnel and also noted that alternative materials are not without clinical limitations and lexicological hazards. The ADA Council on Scientific Affairs prepared a comprehensive literature review (PDF) on amalgam safety that summarizes the state of the evidence for amalgam safety over the last five years (from January 2004 to April 2009). Based on the results of this review, the Council reaffirmed at its July 2009 meeting that the scientific evidence supports the position that amalgam is a valuable, viable and safe choice for dental patients. On July 28, 2009, the U.S. Food and Drug Administration (FDA) issued its final ruje on encapsulated dental amalgam classifying amalgam and its component parts, elemental mercury and powder alloy, as a class II medical device. Previously there was no classification for encapsulated amalgam, and dental mercury (class I) and alloy (class II) were classified separately. This new regulation places encapsulated amalgam in the same ' Of 2 class of devices as most other restorative materials, including composite and gold fillings. At the same time,3t(29/2013 7:07 AM

5 Statement on Dental Amalgam - American Dental Association - ADA.org medical device. Previously there was no classification for encapsulated amalgam, and dental mercury (class I) and alloy (class II) were classified separately. This new regulation places encapsulated amalgam in the same class of devices as most other restorative materials, including composite and gold fillings. At the same time, the FDA also reaffirmed the agency's position that the material is a safe and effective restorative option for patients. The CSA supports ongoing research on the safety of existing dental materials and in the development of new materials, and continues to believe that amalgam is a valuable, viable and safe choice for dental patients. Footnotes i. FDI Policy Statement/WHO Consensus Statement on Dental Amalgam. September ii. ADA Council on Scientific Affairs. Dental Amalgam: Update on Safety Concerns. J Am Dent Assoc. 1998;129: iii. SaxeSR etal. Alzheimer's disease, dental amalgam and mercury J Am Dent Assoc. 1999; 130: iv. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury - Current exposures and clinical manifestations. N Engl J Med. 2003;349: v. Brownawell AM et al. The Potential Adverse Health Effects of Dental Amalgam. Toxicol Rev. 2005:24:1-10. vi. Bellinger DC, Trachtenberg F, Barregard L, Tavares M, Cemichiari E, Daniel D, McKinlay S. Neuropsychological and Renal Effects of Dental Amalgam in Children: A Randomized Clinical Trial. JAMA 2006:295: vii. Bellinger DC, Daniel D, Trachtenberg F, Tavares M, KcKinlay. Dental Amalgam Restorations and Children's Neuropsychological Function: The New England Children's Amalgam Trial. Environ Health Perspect (online 30 October 2006). viii. DeRouen TA, Martin MD, Leroux BG, Townes BD, Wfeods JS, Leitao J, Castro-Caldas A, Luis H, Bernardo M, Rosenbaum G, Martins IP Neurobehavioral Effects of Dental Amalgam in Children: A Randomized Clinical Trial. JAMA 2006;295: ix. European Commission: Scientific Committee on Emerging and Newly Identified Health Risks. The Safety of Dental Amalgam and Alternative Dental Restoration Materials for Patients and Users May 8, 2008 (accessed June 17, 2008). 3/29/2013 7:07 AM

Amalgam Safety and Cost-Effectiveness: An Annotated Bibliography

Amalgam Safety and Cost-Effectiveness: An Annotated Bibliography Amalgam Safety and Cost-Effectiveness: An Annotated Bibliography Contents A.1 Recent policy statements and reviews from major organizations 1) Life Sciences Research Office. Review and analysis of literature

More information

Dental amalgams & alternative materials

Dental amalgams & alternative materials page 1/8 Source document: Tooth filling materials SCENIHR / SCHER (2008) Dental amalgams & alternative materials Summary & Details: GreenFacts Context - Amalgam is a combination of mercury with other metals

More information

Mercury Amalgam and Other Filling Materials

Mercury Amalgam and Other Filling Materials STATE OF CONNECTICUT DEPARTMENT OF ENVIRONMENTAL PROTECTION 79 Elm Street Hartford, CT 06106-5127 1-877-537-2488 www.ct.gov/dep Daniel C. Esty, Commissioner Fillings: The Choices You Have Mercury Amalgam

More information

dental fillings facts About the brochure:

dental fillings facts About the brochure: dental fillings facts About the brochure: Your dentist is dedicated to protecting and improving oral health while providing safe dental treatment. This fact sheet provides information you need to discuss

More information

Dental Amalgam - Its Clinical Use and Disposal

Dental Amalgam - Its Clinical Use and Disposal Guideline Department of Health, NSW 73 Miller Street North Sydney NSW 2060 Locked Mail Bag 961 North Sydney NSW 2059 Telephone (02) 9391 9000 Fax (02) 9391 9101 http://www.health.nsw.gov.au/policies/ Dental

More information

Module 4. Mercury Use in Health Care Settings. - For governments -

Module 4. Mercury Use in Health Care Settings. - For governments - Module 4 Mercury Use in Health Care Settings - For governments - Learning Objectives Identify main mercury issues in the health care sector context Understand common mercury issues within the health care

More information

Clinical Studies & Amalgam Information

Clinical Studies & Amalgam Information Clinical Studies & Amalgam Information DENTAL AMALGAM Do amalgam fillings contain mercury? Yes. Does mercury escape from amalgam fillings? Yes. Have the levels of mercury released by amalgam fillings

More information

Water Fluoridation- All you need to know...

Water Fluoridation- All you need to know... Water Fluoridation- All you need to know... Dental decay is the most common chronic disease in children, affecting 5-8 times as many children than asthma (1). The use of water fluoridation for the prevention

More information

Composite Resin and Amalgam Dental Filling Materials: A Review of Safety, Clinical Effectiveness and Cost-effectiveness

Composite Resin and Amalgam Dental Filling Materials: A Review of Safety, Clinical Effectiveness and Cost-effectiveness TITLE: Composite Resin and Amalgam Dental Filling Materials: A Review of Safety, Clinical Effectiveness and Cost-effectiveness DATE: 22 June 2012 CONTEXT AND POLICY ISSUES Dental caries is a major public

More information

Epilepsy 101: Getting Started

Epilepsy 101: Getting Started American Epilepsy Society 1 Epilepsy 101 for nurses has been developed by the American Epilepsy Society to prepare professional nurses to understand the general issues, concerns and needs of people with

More information

Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole)

Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole) EMA/303592/2015 Summary of the risk management plan (RMP) for Aripiprazole Pharmathen (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Pharmathen, which details the measures

More information

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes Gulf War and Health: Update of Health Effects of Serving in the Gulf War Statement of Stephen L. Hauser, M.D. Professor and Chair of Neurology University of California, San Francisco, School of Medicine

More information

GENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW EFFICACY IN PEOPLE WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN LARGE PHASE III STUDY

GENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW EFFICACY IN PEOPLE WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN LARGE PHASE III STUDY NEWS RELEASE Media Contact: Tara Iannuccillo (650) 467-6800 Investor Contacts: Stefan Foser Karl Mahler (650) 467-2016 011 41 61 687 8503 GENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW

More information

AN ABSTRACT OF THE THESIS OF

AN ABSTRACT OF THE THESIS OF AN ABSTRACT OF THE THESIS OF Matthew J. Young for the degree of Honors Baccalaureate of General Science presented on April 30, 2008. Title: Dental Amalgam Fillings: The Scientific Evidence for Safety Abstract

More information

Are Your Fillings. You? Poisoning. Mercury is a poison more toxic than lead or arsenic

Are Your Fillings. You? Poisoning. Mercury is a poison more toxic than lead or arsenic Mercury is a poison more toxic than lead or arsenic Sam Ziff Are Your Fillings Poisoning You? Mercury is the most poisonous, non-radioactive, naturally occurring substance on our planet. Tom McGuire, author

More information

The Dangerous Truth About Dental Fillings

The Dangerous Truth About Dental Fillings The Dangerous Truth About Dental Fillings www.harrelldentistry.com Open your mouth and take a good look inside. If you ve had any type of dental work done in say, oh the last 150 years, chances are you

More information

SPECIAL REPORT 10 REASONS TO AVOID MERCURY FILLINGS. By Dr. Nicholas J. Meyer. www.milldental.com

SPECIAL REPORT 10 REASONS TO AVOID MERCURY FILLINGS. By Dr. Nicholas J. Meyer. www.milldental.com SPECIAL REPORT 10 REASONS TO AVOID MERCURY FILLINGS By Dr. Nicholas J. Meyer www.milldental.com ABOUT Dr. Meyer Dr. Nicholas J. Meyer has been in practice since 1979. Over the years he developed an almost

More information

5.1 Surround Sound, Dolby Stereo World Premiere: Garden State Film Festival, March 2015 Theatrical Premiere: IFC Center, October 14, 2015

5.1 Surround Sound, Dolby Stereo World Premiere: Garden State Film Festival, March 2015 Theatrical Premiere: IFC Center, October 14, 2015 Description Evidence of Harm chronicles the lives of three ordinary Americans who become reluctant health advocates after suffering from the devastating effects of exposure to hazardous mercury vapors

More information

FACTS about. MENTOR MemoryGel. Silicone Gel Filled Breast Implants

FACTS about. MENTOR MemoryGel. Silicone Gel Filled Breast Implants FACTS about MENTOR MemoryGel Silicone Gel Filled Breast Implants Are you considering breast implant surgery but not certain which type of implant to choose? You re not alone. Science-based information

More information

Mercury in Dentistry: The Facts

Mercury in Dentistry: The Facts Mercury in Dentistry: The Facts Jennifer K. Blake, CDA, EFDA, MADAA Continuing Education Units: 2 hours Online Course: www.dentalcare.com/en-us/dental-education/continuing-education/ce88/ce88.aspx Disclaimer:

More information

Issues Regarding Use of Placebo in MS Drug Trials. Peter Scott Chin, MD Novartis Pharmaceuticals Corporation

Issues Regarding Use of Placebo in MS Drug Trials. Peter Scott Chin, MD Novartis Pharmaceuticals Corporation Issues Regarding Use of Placebo in MS Drug Trials Peter Scott Chin, MD Novartis Pharmaceuticals Corporation Context of the Guidance The draft EMA Guidance mentions placebo as a comparator for superiority

More information

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics Mitzi Joi Williams, MD Neurologist MS Center of Atlanta, Atlanta, GA Disclosures Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

More information

Adoption of N.J.A.C. 8:57-4 (Immunization of Pupils In School) with Amendments and New Rules

Adoption of N.J.A.C. 8:57-4 (Immunization of Pupils In School) with Amendments and New Rules JON S. CORZINE Governor DEPARTMENT OF HEALTH AND SENIOR SERVICES PO BOX 360 TRENTON, N.J. 08625-0360 www.nj.gov/health FRED M. JACOBS, M.D., J.D. Commissioner TO: FROM: SUBJECT: Herbert Yardley, M.A. Chair

More information

Kids Smiles Children s Dental Office

Kids Smiles Children s Dental Office Dear New Patient Parents: Kids Smiles Children s Dental Office Welcome to Kids Smiles! Thank you so much for coming in today. We hope you have an enjoyable visit. Kids Smiles was founded on Martin Luther

More information

THE CASE AGAINST MERCURY IN DENTAL AMALGAM

THE CASE AGAINST MERCURY IN DENTAL AMALGAM THE CASE AGAINST MERCURY IN DENTAL AMALGAM Dental amalgam should have no role in modern dentistry. It is a 200 year old technology containing 50% mercury, which exposes a significant part of the community

More information

What is Multiple Sclerosis? Gener al information

What is Multiple Sclerosis? Gener al information What is Multiple Sclerosis? Gener al information Kim, diagnosed in 1986 What is MS? Multiple sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system (brain and spinal

More information

Wilson Disease. National Digestive Diseases Information Clearinghouse

Wilson Disease. National Digestive Diseases Information Clearinghouse Wilson Disease National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is Wilson disease? Wilson disease is a genetic disorder

More information

National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook

National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook National MS Society Information Sourcebook www.nationalmssociety.org/sourcebook Chemotherapy The literal meaning of the term chemotherapy is to treat with a chemical agent, but the term generally refers

More information

Inorganic mercury/ elemental mercury General information

Inorganic mercury/ elemental mercury General information Inorganic mercury/ elemental mercury General information Key Points Fire Does not easily burn under normal conditions Reacts with nitric acid and hot concentrated sulphuric acid. May react explosively

More information

CLASSIFICATION OF CARIOUS LESIONS AND TOOTH PREPARATION.

CLASSIFICATION OF CARIOUS LESIONS AND TOOTH PREPARATION. CLASSIFICATION OF CARIOUS LESIONS AND TOOTH PREPARATION. ١ G.V. BLACK who is known as the father of operative dentistry,he classified carious lesions into groups according to their locations in permanent

More information

PLEASE READ THE FOLLOWING ONLINE PRE REGISTRATION PREDOCTORAL CLINIC POLICIES AND CONSENTS

PLEASE READ THE FOLLOWING ONLINE PRE REGISTRATION PREDOCTORAL CLINIC POLICIES AND CONSENTS PLEASE READ THE FOLLOWING ONLINE PRE REGISTRATION PREDOCTORAL CLINIC POLICIES AND CONSENTS Please print the last page and bring to your appointment as an acknowledgement that you have read/received our

More information

AMPYRA (dalfampridine) Important Safety Information

AMPYRA (dalfampridine) Important Safety Information NEWS RELEASE Acorda to Present New rhigm22 and AMPYRA (dalfampridine) Data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 10/7/2015 ARDSLEY, N.Y.--(BUSINESS

More information

Regulating Mercury Amalgam Use at Private Dental Clinics in Pakistan

Regulating Mercury Amalgam Use at Private Dental Clinics in Pakistan Policy Brief # 45 Regulating Mercury Amalgam Use at Private Dental Clinics in Pakistan By: Mahmood A. Khwaja and S.Waqar Ali All rights reserved. No part of this paper may be reproduced or transmitted

More information

SAMPLE DENTAL SEALANT AGENCY PROTOCOL

SAMPLE DENTAL SEALANT AGENCY PROTOCOL SAMPLE DENTAL SEALANT AGENCY PROTOCOL Wisconsin Department of Health and Family Services Division of Public Health April 25, 2005 Table of Contents I. Sample Dental Sealant Policy...3 II. III. IV. Sample

More information

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients

Oxford University Hospitals. NHS Trust. Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis. Information for patients Oxford University Hospitals NHS Trust Department of Neurology Natalizumab (Tysabri) for Multiple Sclerosis Information for patients page 2 What is Natalizumab and what is it used for? Natalizumab is an

More information

Participating in Alzheimer s Disease Clinical Trials and Studies

Participating in Alzheimer s Disease Clinical Trials and Studies Participating in Alzheimer s Disease Clinical Trials and Studies FACT SHEET When Margaret was diagnosed with earlystage Alzheimer s disease at age 68, she wanted to do everything possible to combat the

More information

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004.

Understanding. Multiple Sclerosis. Tim, diagnosed in 2004. Understanding Multiple Sclerosis Tim, diagnosed in 2004. What Is Multiple Sclerosis? Multiple sclerosis (MS) is a neurologic disorder that affects the central nervous system (CNS). The CNS includes the

More information

Biologic Treatments for Rheumatoid Arthritis

Biologic Treatments for Rheumatoid Arthritis Biologic Treatments Rheumatoid Arthritis (also known as cytokine inhibitors, TNF inhibitors, IL 1 inhibitor, or Biologic Response Modifiers) Description Biologics are new class of drugs that have been

More information

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them. Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors

More information

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown) UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:

More information

MERCURY TOXICITY: GENETIC SUSCEPTIBILITY AND SYNERGISTIC EFFECTS DR. BOYD E. HALEY PROFESSOR AND CHAIR DEPARTMENT OF CHEMISTRY UNIVERSITY OF KENTUCKY

MERCURY TOXICITY: GENETIC SUSCEPTIBILITY AND SYNERGISTIC EFFECTS DR. BOYD E. HALEY PROFESSOR AND CHAIR DEPARTMENT OF CHEMISTRY UNIVERSITY OF KENTUCKY MERCURY TOXICITY: GENETIC SUSCEPTIBILITY AND SYNERGISTIC EFFECTS DR. BOYD E. HALEY PROFESSOR AND CHAIR DEPARTMENT OF CHEMISTRY UNIVERSITY OF KENTUCKY VISUALIZATION OF MERCURY EMITTING FROM A DENTAL AMALGAM

More information

Not All Clinical Trials Are Created Equal Understanding the Different Phases

Not All Clinical Trials Are Created Equal Understanding the Different Phases Not All Clinical Trials Are Created Equal Understanding the Different Phases This chapter will help you understand the differences between the various clinical trial phases and how these differences impact

More information

Requisite Approval must be attached

Requisite Approval must be attached Requisite Approval must be attached CITRUS COMMUNITY COLLEGE DISTRICT DEPARTMENT Health Occupations COURSE NUMBER DENT 122 TITLE Infection Control in the Dental Office THIS COURSE IS CLASSIFIED AS: DEGREE

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Hunter syndrome is a rare genetic disease which mainly affects males of all ethnicities. The incidence rate ranges from 0.6 to

More information

STATISTICAL BRIEF #113

STATISTICAL BRIEF #113 Medical Expenditure Panel Survey STATISTICAL BRIEF #113 Agency for Healthcare Research and Quality January 26 Children s Dental Care: Periodicity of Checkups and Access to Care, 23 May Chu Introduction

More information

1. PUBLIC HEALTH STATEMENT. This public health statement tells you about hydraulic fluids and the effects of exposure.

1. PUBLIC HEALTH STATEMENT. This public health statement tells you about hydraulic fluids and the effects of exposure. HYDRAULIC FLUIDS 1 This public health statement tells you about hydraulic fluids and the effects of exposure. The Environmental Protection Agency (EPA) identifies the most serious hazardous waste sites

More information

May 22, 2015. Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216

May 22, 2015. Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 May 22, 2015 Rachel s

More information

Travel to Africa 2005. David V. Diamond, MD MIT Medical Department

Travel to Africa 2005. David V. Diamond, MD MIT Medical Department Travel to Africa 2005 David V. Diamond, MD MIT Medical Department 1 General Advice: Overall risks are low for diseases other than Traveler's diarrhea Preventative measures to avoid exposure to mosquito

More information

Effect of occupational exposures on male fertility: literature review, Ind Health. 2003 Apr;41(2):55-62.

Effect of occupational exposures on male fertility: literature review, Ind Health. 2003 Apr;41(2):55-62. The most recent statistics show that 2 out of every 10 couples trying to achieve pregnancy will be diagnosed with infertility. For many, this can be an extremely difficult diagnosis to accept and to understand.

More information

REACH Understanding the Risk Assessment Process

REACH Understanding the Risk Assessment Process _experience the commitment TM REACH Understanding the Risk Assessment Process Introduction Across virtually every segment of society, we witness how chemicals have delivered significant benefits to society.

More information

Summary of the risk management plan (RMP) for Cerdelga (eliglustat)

Summary of the risk management plan (RMP) for Cerdelga (eliglustat) EMA/743948/2014 Summary of the risk management plan (RMP) for Cerdelga (eliglustat) This is a summary of the risk management plan (RMP) for Cerdelga, which details the measures to be taken in order to

More information

Submission: REF Fluoridation Plants Including the Ballina Shire Council Marom Creek Supply

Submission: REF Fluoridation Plants Including the Ballina Shire Council Marom Creek Supply 4 th February 2010 Attn: The General Manager Rous Water water@rouswater.nsw.gov.au Submission prepared by Jo Immig NTN Coordinator Submission: REF Fluoridation Plants Including the Ballina Shire Council

More information

Depression in Older Persons

Depression in Older Persons Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression

More information

Exposure. What Healthcare Personnel Need to Know

Exposure. What Healthcare Personnel Need to Know Information from the Centers for Disease Control and Prevention National Center for Infectious Diseases Divison of Healthcare Quality Promotion and Division of Viral Hepatitis For additional brochures

More information

Clinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved

Clinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved Clinical and Therapeutic Cannabis Information Written by Cannabis Training University (CTU) All rights reserved Contents Introduction... 3 Chronic Pain... 6 Neuropathic Pain... 8 Movement Disorders...

More information

3 Food Standards Agency, London, UK

3 Food Standards Agency, London, UK Chapter six From Hazard to Risk e Assessing the Risk Charlotte Bernhard Madsen 1, Geert Houben 2, Sue Hattersley 3, Rene W.R. Crevel 4, Ben C. Remington 5, Joseph L. Baumert 5 1 DVM Research Leader Division

More information

Document issued on: December 2, 2014. The draft of this document was issued on March 11, 2013. Contains Nonbinding Recommendations

Document issued on: December 2, 2014. The draft of this document was issued on March 11, 2013. Contains Nonbinding Recommendations Recommendations for Labeling Medical Products to Inform Users that the Product or Product Container is not Made with Natural Rubber Latex Guidance for Industry and Food and Drug Administration Staff Document

More information

The Clinical Trials Process an educated patient s guide

The Clinical Trials Process an educated patient s guide The Clinical Trials Process an educated patient s guide Gwen L. Nichols, MD Site Head, Oncology Roche TCRC, Translational and Clinical Research Center New York DISCLAIMER I am an employee of Hoffmann-

More information

Original Policy Date

Original Policy Date MP 5.01.20 Tysabri (natalizumab) Medical Policy Section Prescription Drug Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Local Policy/12:2013 Return to Medical Policy Index Disclaimer

More information

Appendix Chapter 2: Instructional Programs

Appendix Chapter 2: Instructional Programs Appendix 2.6.b.i. Core Public Courses at the School Mapped to Version 2.2 Association of Schools of Public (ASPH) Core Competencies: July 2006 Domain: 1 Describe the roles biostatistics serves in the discipline

More information

100% WHEY PROTEIN PARTIALLY HYDROLYZED in Infant Formula and REDUCING THE RISK OF ALLERGY IN INFANTS EXECUTIVE SUMMARY

100% WHEY PROTEIN PARTIALLY HYDROLYZED in Infant Formula and REDUCING THE RISK OF ALLERGY IN INFANTS EXECUTIVE SUMMARY QUALIFIED HEALTH CLAIM PETITION 100% WHEY PROTEIN PARTIALLY HYDROLYZED in Infant Formula and REDUCING THE RISK OF ALLERGY IN INFANTS EXECUTIVE SUMMARY The prevalence of allergic (atopic) diseases continues

More information

Best Management Practices for Mercury Waste Management in Dental Offices

Best Management Practices for Mercury Waste Management in Dental Offices Best Management Practices for Mercury Waste Management in Dental Offices Mercury Waste Best Management Practices (BMPs) for Dental Facilities are designed to comply with environmental regulations, prevent

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: PDP IBT Inj - Vivitrol Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Opiate Antagonist Client: 2007 PDP IBT Inj Approval Date: 2/20/2007

More information

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 11, 2015 Next Review Date: December 2016 Effective Date: January

More information

A Parent s Guide to Understanding Congenital Hypothyroidism. Children s of Alabama Department of Pediatric Endocrinology

A Parent s Guide to Understanding Congenital Hypothyroidism. Children s of Alabama Department of Pediatric Endocrinology A Parent s Guide to Understanding Congenital Hypothyroidism Children s of Alabama Department of Pediatric Endocrinology How did you get here? Every baby born in the state of Alabama is required by law

More information

CRITIQUE OF THE CHILDREN S AMALGAM STUDY CONSENT FORMS (American forms and Portuguese forms)

CRITIQUE OF THE CHILDREN S AMALGAM STUDY CONSENT FORMS (American forms and Portuguese forms) CRITIQUE OF THE CHILDREN S AMALGAM STUDY CONSENT FORMS (American forms and Portuguese forms) Summary of critique. The Children s Amalgam Study is an $11 million study which began in 1997 to prove the null

More information

Side effects of mercury in dental amalgam

Side effects of mercury in dental amalgam 30 Side effects of mercury in dental amalgam Titiek Berniyanti and Ninuk Hariyani Faculty of Dentistry Airlangga University of Dental Public Health Department Surabaya - Indonesia abstract Dental amalgam

More information

Medication-Assisted Addiction Treatment

Medication-Assisted Addiction Treatment Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling

More information

Clinical Trials of Disease Modifying Treatments

Clinical Trials of Disease Modifying Treatments MS CENTER CLINICAL RESEARCH The UCSF MS Center is an internationally recognized leader in multiple sclerosis clinical research. We conduct clinical trials involving the use of experimental treatments,

More information

Methadone gets in your bones. Myth

Methadone gets in your bones. Myth gets in your bones. does not get into the bones or in any other way cause harm to the skeletal system. Although some methadone patients report having aches in their arms and legs, the discomfort is probably

More information

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS Disease Modifying Therapies for MS The term disease-modifying therapy means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks

More information

Mad as a Hatter. The Dental Amalgam Debate By E. Griffin Cole, D.D.S.

Mad as a Hatter. The Dental Amalgam Debate By E. Griffin Cole, D.D.S. Mad as a Hatter The Dental Amalgam Debate By E. Griffin Cole, D.D.S. I recently attended a very important international dental seminar in Scottsdale, Arizona. Several prominent physicians and dentists

More information

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Effective Date: January

More information

1. PUBLIC HEALTH STATEMENT

1. PUBLIC HEALTH STATEMENT 1 This Statement was prepared to give you information about fuel oils and to emphasize the human health effects that may result from exposure to them. The Environmental Protection Agency (EPA) has identified

More information

ACKNOWLEDGEMENT OF RECEIPT OF WESTERN DENTAL S NOTICE OF PRIVACY PRACTICE

ACKNOWLEDGEMENT OF RECEIPT OF WESTERN DENTAL S NOTICE OF PRIVACY PRACTICE ACKNOWLEDGEMENT OF RECEIPT OF WESTERN DENTAL S NOTICE OF PRIVACY PRACTICE By signing this document, I acknowledge that I have received a copy of Western Dental s Joint Notice of Privacy Practices. Name

More information

American Society of Addiction Medicine

American Society of Addiction Medicine American Society of Addiction Medicine Public Policy Statement on Parity in Benefit Coverage: A Joint Statement by ASAM and AMBHA The American Managed Behavioral Healthcare Association (AMBHA) and the

More information

Central Texas College. Psychology 2301. General Psychology

Central Texas College. Psychology 2301. General Psychology Central Texas College Psychology 2301 General Psychology I. Introduction A. General Psychology is a survey of the major psychological topics, theories, and approaches to the scientific study of behavior

More information

WHY MASS MEDICATION WITH FLUORIDE MUST STOP NOW! Alliance for Natural Health International Position Paper September 2012

WHY MASS MEDICATION WITH FLUORIDE MUST STOP NOW! Alliance for Natural Health International Position Paper September 2012 ANH International The Atrium, Curtis Road Dorking, Surrey RH4 1XA United Kingdom e: info@anhinternational.org t: +44 (0)1306 646 600 f: +44 (0)1306 646 552 www.anhinternational.org ANH-Intl Regional Offices

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

Trauma Insurance Claims Seminar Invitation

Trauma Insurance Claims Seminar Invitation Trauma Insurance Claims Seminar Invitation Introduction Since the development of Trauma Insurance in Australia in the 1980s, the product has evolved at a great pace. Some of the challenges faced by claims

More information

Health Concerns: A Brief Overview of the Effects of Dental Amalgam on the Teeth and Body by C. Michael Willock, DDS 2008 Chapel Hill, NC

Health Concerns: A Brief Overview of the Effects of Dental Amalgam on the Teeth and Body by C. Michael Willock, DDS 2008 Chapel Hill, NC Health Concerns: A Brief Overview of the Effects of Dental Amalgam on the Teeth and Body by C. Michael Willock, DDS 2008 Chapel Hill, NC There are several reasons why the use of dental amalgam may not

More information

Fluoride. Introduction

Fluoride. Introduction Fluoride Introduction Most fluoride in the body is found in bones and teeth, due to its high affinity for calcium and calcium phosphate. Ingestion of and topical treatment with fluoride is effective in

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

What Patients Don t Know: Dentists Sweet Tooth for Mercury

What Patients Don t Know: Dentists Sweet Tooth for Mercury What Patients Don t Know: Dentists Sweet Tooth for Mercury February 14, 2006 Acknowledgements The authors would like to thank the Garfield Foundation, the John Merck Fund the Orchard Foundation, and the

More information

Cognitive Testing for Underwriting Life Insurance

Cognitive Testing for Underwriting Life Insurance Cognitive Testing for Underwriting Life Insurance Presentation to the Mortality Working Group of the International Actuarial Association Al Klein April 8, 2011 Cognitive function Agenda What is it? What

More information

Table of Contents TABLE OF CONTENTS 2 WHY THEY SHOULDN'T BE CALLED SILVER FILLINGS 5. Even one amalgam filling... May be one too many!

Table of Contents TABLE OF CONTENTS 2 WHY THEY SHOULDN'T BE CALLED SILVER FILLINGS 5. Even one amalgam filling... May be one too many! Table of Contents TABLE OF CONTENTS 2 INTRODUCTION 3 WHY THEY SHOULDN'T BE CALLED SILVER FILLINGS 5 Even one amalgam filling... May be one too many! 7 How Mercury Destroys Your Health 8 What Are Some of

More information

University of Maryland School of Medicine Master of Public Health Program. Evaluation of Public Health Competencies

University of Maryland School of Medicine Master of Public Health Program. Evaluation of Public Health Competencies Semester/Year of Graduation University of Maryland School of Medicine Master of Public Health Program Evaluation of Public Health Competencies Students graduating with an MPH degree, and planning to work

More information

2.1 Who first described NMO?

2.1 Who first described NMO? History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first

More information

Summary of the risk management plan (RMP) for Rasagiline ratiopharm (rasagiline)

Summary of the risk management plan (RMP) for Rasagiline ratiopharm (rasagiline) EMA/744222/2014 Summary of the risk management plan (RMP) for Rasagiline ratiopharm (rasagiline) This is a summary of the risk management plan (RMP) for Rasagiline ratiopharm, which details the measures

More information

NUVIGIL (armodafinil) oral tablet

NUVIGIL (armodafinil) oral tablet NUVIGIL (armodafinil) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

CONSENT FORM 12/19/08

CONSENT FORM 12/19/08 12/19/08 1001 University Place Evanston, Illinois 60201 www.northshore.org CONSENT FORM Phone (224) 364-7100 Fax (847) 570-8011 Intravesical Alkalized Lidocaine for the Treatment of Overactive Bladder

More information

Mold Questions and Answers Questions and Answers on Stachybotrys chartarum and other molds

Mold Questions and Answers Questions and Answers on Stachybotrys chartarum and other molds Questions and Answers on Stachybotrys chartarum and other molds Questions and Answers 1. I heard about "toxic molds" that grow in homes and other buildings. Should I be concerned about a serious health

More information

Remeron (mirtazapine)

Remeron (mirtazapine) Remeron (mirtazapine) FDA ALERT [07/2005] Suicidal Thoughts or Actions in Children and Adults Patients with depression or other mental illnesses often think about or attempt suicide. Closely watch anyone

More information

How To Write A Recipe Card

How To Write A Recipe Card Joanne R. Festa, PhD (PLEASE PRINT) NAME: DATE OF BIRTH: NEUROPSYCHOLOGY INITIAL VISIT DATE: AGE: Do you have any areas of concern about your cognitive functioning? (i.e., problems with memory, attention,

More information

MS Learn Online Feature Presentation Understanding MS Research Robert Lisak, MD. Tom>> And I'm Tom Kimball. Welcome to MS Learn Online.

MS Learn Online Feature Presentation Understanding MS Research Robert Lisak, MD. Tom>> And I'm Tom Kimball. Welcome to MS Learn Online. Tracey>> Hi I'm Tracey Kimball MS Learn Online Feature Presentation Understanding MS Research Robert Lisak, MD Tom>> And I'm Tom Kimball. Welcome to MS Learn Online. Tracey>> There's so much to learn when

More information

Variation in Urban and Rural Water Fluoride Levels in Ontario

Variation in Urban and Rural Water Fluoride Levels in Ontario Professional I s s u e s Variation in Urban and Rural Water Fluoride Levels in Ontario James Yarmolinsky; Savithiri Ratnapalan, MBBS, MRCP, FAAP, FRCPC, MEd; David J. Kenny, DDS, PhD, FRCD(C) Contact Author

More information

Communicating uncertainty about benefits and

Communicating uncertainty about benefits and Communicating uncertainty about benefits and harms of pharmaceutical products Lisa M. Schwartz, MD, MS Steven Woloshin, MD, MS The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth

More information

NIOSH Publishes Study of Cancer Among Firefighters Claire Reiss National League of Cities Risk Information Sharing Consortium.

NIOSH Publishes Study of Cancer Among Firefighters Claire Reiss National League of Cities Risk Information Sharing Consortium. NIOSH Publishes Study of Cancer Among Firefighters Claire Reiss National League of Cities Risk Information Sharing Consortium The National Institute for Occupational Safety and Health has released the

More information

Oral health and MS. Factsheet. How might MS affect my oral health? September 2012

Oral health and MS. Factsheet. How might MS affect my oral health? September 2012 Factsheet September 2012 Oral health and MS MS (multiple sclerosis) doesn't directly make you more likely to get dental problems than other people. But it might make it harder for you to maintain good

More information

Unit/Standard Number. Proficiency Level Achieved: (X) Indicates Competency Achieved to Industry Proficiency Level

Unit/Standard Number. Proficiency Level Achieved: (X) Indicates Competency Achieved to Industry Proficiency Level 1 Secondary Task List 100 INTRODUCTION TO HEALTHCARE 101 Identify the roles and educational/credentialing requirements of various health care practitioners. 102 Describe the 's job description, personal

More information